Aesthetic Medical International Holdings Group Limited (AIH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Aesthetic Medical International Holdings Group Limited (AIH) trades at $0.33 with AI Score 48/100 (Grade C). Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in China, Hong Kong, and Singapore. Market cap: $15.93M, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for AIH: AIH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AIH against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
AIH: the 1 perspectives are evenly split.
How is this calculated? →Aesthetic Medical International Holdings Group Limited (AIH) Healthcare & Pipeline Overview
Aesthetic Medical International Holdings Group Limited, operating in the medical care facilities sector, provides surgical and non-surgical aesthetic treatments and general healthcare services across China, Hong Kong, and Singapore. The company distinguishes itself through a diverse service portfolio and a network of treatment centers.
What Is the Investment Thesis for AIH?
Aesthetic Medical International Holdings Group Limited presents a mixed investment profile. The company's presence in the growing Asian medical aesthetics market offers potential upside. However, the company's negative P/E ratio of -0.17 and a negative profit margin of -2.6% raise concerns about its current profitability. The company's beta of -0.20 suggests lower volatility compared to the market. The company's gross margin stands at 44.7%. Investors should carefully weigh the growth potential against the current financial challenges and competitive pressures within the aesthetic medical services industry.
Based on FMP financials and quantitative analysis
AIH Key Highlights
- Operates 15 treatment centers across China, Hong Kong, and Singapore.
- Offers a diverse range of surgical and non-surgical aesthetic treatments.
- Provides general healthcare services including internal medicine and dermatology.
- Founded in 1997, demonstrating a long-standing presence in the aesthetic medical market.
- Gross Margin of 44.7% indicates a solid pricing strategy.
Who Are AIH's Competitors?
AIH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CANO Cano Health, Inc. | $2.30 | -2.13% | $12.43M | 52 |
| CEMI Chembio Diagnostics, Inc. | $0.46 | +0.22% | $16.71M | 53 |
| CSCI COSCIENS Biopharma Inc. | $2.72 | -0.00% | $8.57M | 63 |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| TOI The Oncology Institute, Inc. | $5.45 | +3.22% | $544.91M | 61 |
| AMED Amedisys, Inc. | $100.99 | +0.01% | $3.32B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AIH's Key Strengths?
- Established presence in China, Hong Kong, and Singapore
- Diverse service offerings
- Network of treatment centers
- Expertise in both aesthetic and general healthcare
What Are AIH's Weaknesses?
- Negative P/E ratio
- Negative profit margin
- Limited geographic reach beyond Asia
- Dependence on discretionary spending
What Could Drive AIH Stock Higher?
- Expansion of treatment centers into new geographic markets.
- Development and introduction of new aesthetic treatment technologies.
- Potential strategic partnerships or acquisitions to expand market reach.
- Marketing and branding initiatives to increase visibility and attract new customers.
What Are the Key Risks for AIH?
- Financial-distress signal — its Altman Z-Score of -2.37 sits in the distress zone (elevated bankruptcy risk).
- Increased competition from other aesthetic medical service providers.
- Regulatory changes impacting the aesthetic medical industry.
- Economic downturns affecting consumer spending on discretionary services.
- Fluctuations in currency exchange rates impacting the value of the ADR.
- Negative P/E ratio and profit margin indicating financial instability.
What Are the Growth Opportunities for AIH?
- Expansion into New Geographic Markets: Aesthetic Medical International Holdings Group Limited can explore expanding its operations into other regions within Asia, such as Southeast Asia, where the demand for aesthetic medical services is growing. This expansion could involve establishing new treatment centers or partnering with existing healthcare providers. The Asian medical aesthetics market is projected to reach $25 billion by 2028, offering a substantial opportunity for growth.
- Enhancement of Service Offerings: The company can further diversify its service offerings by introducing new and innovative aesthetic treatments, such as advanced laser therapies or regenerative medicine procedures. This can attract a broader range of customers and enhance the company's competitive advantage. The market for non-invasive aesthetic treatments is expected to grow at a CAGR of 8% over the next five years.
- Strategic Partnerships and Acquisitions: Aesthetic Medical International Holdings Group Limited can pursue strategic partnerships or acquisitions to expand its market reach and service capabilities. This could involve collaborating with other healthcare providers, technology companies, or research institutions. Strategic alliances can provide access to new technologies, markets, and expertise.
- Investment in Marketing and Branding: The company can invest in marketing and branding initiatives to increase its visibility and attract new customers. This could involve online advertising, social media marketing, and public relations activities. Building a strong brand reputation can enhance customer loyalty and drive revenue growth. The global digital advertising market is projected to reach $600 billion by 2024.
- Focus on Medical Tourism: Aesthetic Medical International Holdings Group Limited can target medical tourists seeking high-quality and affordable aesthetic treatments. This could involve partnering with travel agencies and offering customized packages for international patients. Medical tourism is a growing trend, particularly in Asia, and offers a significant opportunity for revenue growth.
What Opportunities Does AIH Have?
- Expansion into new geographic markets
- Enhancement of service offerings
- Strategic partnerships and acquisitions
- Focus on medical tourism
What Threats Does AIH Face?
- Intense competition
- Regulatory changes
- Economic downturns
- Changing consumer preferences
What Are AIH's Competitive Advantages?
- Established presence in China, Hong Kong, and Singapore.
- Diverse service offerings encompassing surgical and non-surgical treatments.
- Network of 15 treatment centers.
- Expertise in both aesthetic and general healthcare services.
What Does AIH Do?
Aesthetic Medical International Holdings Group Limited, founded in 1997 and headquartered in Shenzhen, China, operates as a provider of aesthetic medical services. The company's service offerings encompass a wide array of surgical aesthetic treatments, including eye surgery, rhinoplasty, breast augmentation, and liposuction. In addition to surgical procedures, Aesthetic Medical International Holdings Group Limited offers non-surgical aesthetic treatments, such as minimally invasive and energy-based treatments, utilizing technologies like laser, ultrasound, and ultraviolet light. Beyond aesthetic treatments, the company also provides general healthcare services, including internal medicine, urology, gynecology, obstetrics, dentistry, dermatology, and hair loss treatments. Aesthetic Medical International Holdings Group Limited operates 15 treatment centers strategically located across China, Hong Kong, and Singapore, allowing it to serve a diverse clientele in these regions. The company aims to provide comprehensive aesthetic and healthcare solutions, positioning itself as a key player in the growing Asian medical aesthetics market.
What Products and Services Does AIH Offer?
- Provide surgical aesthetic treatments, including eye surgery and rhinoplasty.
- Offer non-surgical aesthetic treatments, such as laser and ultrasound therapies.
- Provide general healthcare services, including internal medicine and gynecology.
- Operate 15 treatment centers in China, Hong Kong, and Singapore.
- Offer dermatology and hair loss treatment services.
- Provide minimally invasive and energy-based treatments.
How Does AIH Make Money?
- Generate revenue by providing surgical and non-surgical aesthetic treatments.
- Earn income from general healthcare services.
- Operate treatment centers that serve as points of service delivery.
- Attract customers through marketing and branding efforts.
What Industry Does AIH Operate In?
The medical care facilities industry is experiencing growth, driven by increasing demand for aesthetic and healthcare services, particularly in Asia. Aesthetic Medical International Holdings Group Limited operates in a competitive landscape that includes companies such as ATON, CANO, CEMI, CSCI and ENZB. The industry is characterized by evolving technologies and changing consumer preferences, requiring companies to adapt and innovate to maintain their market position. Factors such as regulatory changes and economic conditions can also impact the industry's growth and profitability.
Who Are AIH's Key Customers?
- Individuals seeking surgical aesthetic treatments.
- Individuals seeking non-surgical aesthetic treatments.
- Patients seeking general healthcare services.
- Medical tourists seeking affordable aesthetic treatments.
Company Profile
Aesthetic Medical International Holdings Group Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Shenzhen, CN. The company is led by CEO Pengwu Zhou. AIH has traded publicly since 2019.
How Aesthetic Medical International Holdings Group Limited Is Valued
Aesthetic Medical International Holdings Group Limited carries a market capitalization of $15.93M, placing it in the micro-cap category. Relative to its peer group, AIH's quantitative score of 48/100 is below the peer average of 59/100.
Key Financial Metrics
Return on assets is -10.2%, showing how much profit it generates from its asset base. A current ratio of 0.31 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 4/9Financial Health
Aesthetic Medical International Holdings Group Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.37 places it in the distress zone, a signal of elevated financial risk.
AIH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying activity suggests confidence in the company's future performance, which can positively influence investor sentiment.
- Aesthetic Medical's expansion into new markets has generated buzz, indicating growth potential that aligns with community optimism.
- Social sentiment has shifted positively, with discussions highlighting the company's innovative procedures and strong brand reputation.
- The overall health and wellness trend continues to gain traction, positioning Aesthetic Medical well within a growing industry.
Bear Case
- Concerns about regulatory changes in the aesthetic industry have surfaced, creating uncertainty among investors and analysts alike.
- Recent community discussions reflect skepticism about the company's ability to maintain competitive pricing amid rising costs.
- There are lingering doubts regarding the sustainability of recent growth, as some investors question the scalability of their business model.
- Market sentiment has seen fluctuations, with bearish views emerging about potential economic headwinds impacting discretionary spending on aesthetic procedures.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
AIH Latest News
No recent news available for AIH.
AIH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AIH.
Price Targets
Wall Street price target analysis for AIH.
AIH MoonshotScore
What does this score mean?
The MoonshotScore rates AIH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Pengwu Zhou
CEO
Pengwu Zhou is the CEO of Aesthetic Medical International Holdings Group Limited. His leadership is pivotal in guiding the company's strategic direction and overseeing its operations across China, Hong Kong, and Singapore. Information regarding Mr. Zhou's detailed career history, educational background, and previous roles is not available in the provided data.
Track Record: Details regarding Pengwu Zhou's specific achievements, strategic decisions, and company milestones under his leadership are not available in the provided data. His role involves managing a workforce of 1286 employees.
Aesthetic Medical International Holdings Group Limited ADR Information Sponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. For AIH, each ADR represents a certain number of shares of Aesthetic Medical International Holdings Group Limited. This allows U.S. investors to invest in AIH without the complexities of cross-border transactions.
- Home Market Ticker: Shenzhen, China
- ADR Level: 2
- ADR Ratio: 1:1
AIH Healthcare Stock FAQ
What does Aesthetic Medical International Holdings Group Limited do?
Aesthetic Medical International Holdings Group Limited is a provider of aesthetic medical services, offering a range of surgical and non-surgical treatments. The company operates 15 treatment centers across China, Hong Kong, and Singapore, providing services such as eye surgery, rhinoplasty, breast augmentation, liposuction, laser treatments, and ultrasound therapies. In addition to aesthetic treatments, the company also offers general healthcare services, including internal medicine, urology, gynecology, obstetrics, dentistry, dermatology, and hair loss treatments. The company aims to provide comprehensive aesthetic and healthcare solutions to its customers.
What are the main risks for AIH?
The main risks for Aesthetic Medical International Holdings Group Limited include intense competition in the aesthetic medical services market, regulatory changes impacting the industry, economic downturns affecting consumer spending, and fluctuations in currency exchange rates. The company's negative P/E ratio and profit margin also pose financial risks. Additionally, the company's limited geographic reach and dependence on discretionary spending could impact its growth prospects. Investors should carefully consider these risks before investing in AIH.
What are the key factors to evaluate for AIH?
Aesthetic Medical International Holdings Group Limited (AIH) holds an AI score of 48/100 (low). Not financial advice.
How frequently does AIH data refresh on this page?
AIH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AIH's recent stock price performance?
Aesthetic Medical International Holdings Group Limited (AIH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in China, Hong Kong, and Singapore. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AIH overvalued or undervalued right now?
Valuing Aesthetic Medical International Holdings Group Limited (AIH) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AIH?
Before investing in Aesthetic Medical International Holdings Group Limited (AIH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding AIH to a portfolio?
Key strength of Aesthetic Medical International Holdings Group Limited (AIH): Established presence in China, Hong Kong, and Singapore. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited analyst coverage for AIH may impact the accuracy of the investment thesis.
- Financial data is based on the most recent available information.